Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|DCIS
Interventions: DRUG: (Z)-Endoxifen supplementation according to genotype|DRUG: (Z)-Endoxifen supplementation according to plasma levels
Sponsor: Robert Bosch Gesellschaft für Medizinische Forschung mbH